{"0I3.F": {"short_name": "AXONICS MODUL. TECH.", "long_name": "Axonics Modulation Technologies, Inc.", "summary": "Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Irvine"}, "0P8.F": {"short_name": "PENUMBRA INC.", "long_name": "Penumbra, Inc.", "summary": "Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Alameda"}, "111N.F": {"short_name": "SINTX TECHS INC.  DL-,01", "long_name": "Sintx Technologies, Inc.", "summary": "Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. It offers ceramic based biomaterial solutions in various medical and industrial applications. The company provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. Sintx Technologies, Inc. markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Salt Lake City"}, "1N7.F": {"short_name": "NEVRO CORP.  DL-,001", "long_name": "Nevro Corp.", "summary": "Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Redwood City"}, "1P5.SG": {"short_name": "PAVmed Inc. Registered Shares D", "long_name": "PAVmed Inc.", "summary": "PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "STU", "market": "dr_market", "country": "United States", "city": "New York"}, "24OA.F": {"short_name": "OBALON THERAPEUT. DL-,001", "long_name": "Obalon Therapeutics, Inc.", "summary": "Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Carlsbad"}, "24PA.F": {"short_name": "SECOND SIGHT MED.PRODUCT.", "long_name": "Second Sight Medical Products, Inc.", "summary": "Second Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Sylmar"}, "2K3.F": {"short_name": "SI-BONE INC.  DL-,0001", "long_name": "SI-BONE, Inc.", "summary": "SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was founded in 2008 and is headquartered in Santa Clara, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Santa Clara"}, "308.F": {"short_name": "CONFORMIS INC.  DL-,00001", "long_name": "Conformis, Inc.", "summary": "Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Billerica"}, "36M.F": {"short_name": "SHOCKWAVE MEDICAL DL-,001", "long_name": "ShockWave Medical, Inc.", "summary": "ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Santa Clara"}, "46K.F": {"short_name": "IRADIMED CORP.  DL-,0001", "long_name": "IRadimed Corporation", "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Winter Springs"}, "46K.SG": {"short_name": "iRadimed Corp. Registered Share", "long_name": "IRadimed Corporation", "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "STU", "market": "dr_market", "country": "United States", "city": "Winter Springs"}, "46L.SG": {"short_name": "SeaSpine Holdings Corp. Registe", "long_name": "SeaSpine Holdings Corporation", "summary": "SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. The company has development and licensing agreement with restor3d, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "STU", "market": "dr_market", "country": "United States", "city": "Carlsbad"}, "5HJ0.F": {"short_name": "HANC. JAFFE LAB.DL-,00001", "long_name": "Hancock Jaffe Laboratories, Inc.", "summary": "Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It develops and manufactures bioprosthetic implantable devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. operates as a subsidiary of Leman Cardiovascular SA.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Irvine"}, "5TX.F": {"short_name": "SENSUS HEALTHCARE  DL-,01", "long_name": "Sensus Healthcare, Inc.", "summary": "Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Boca Raton"}, "5XS2.F": {"short_name": "LEXAGENE HLDGS", "long_name": "LexaGene Holdings Inc.", "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Beverly"}, "6598.TW": {"short_name": "APPLIED BIOCODE CORPORATION", "long_name": "Applied BioCode Corporation", "summary": "Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. It also develops assays, such as BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and BioCode sexually transmitted infections (STI) panels for detection of common infectious agents causing STDs, as well as MDx assays pipeline for various molecular tests. In addition, the company offers human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Further, it provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. The company was founded in 2016 and is based in Santa Fe Springs, California.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "TAI", "market": "tw_market", "country": "United States", "city": "Santa Fe Springs"}, "6IO.F": {"short_name": "INOGEN INC.  DL -,001", "long_name": "Inogen, Inc.", "summary": "Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Goleta"}, "6L9.F": {"short_name": "VIEWRAY INC.", "long_name": "ViewRay, Inc.", "summary": "ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Oakwood"}, "8HH.F": {"short_name": "AVANOS MEDICAL INC.DL-,01", "long_name": "Avanos Medical, Inc.", "summary": "Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Alpharetta"}, "A1BM34.SA": {"short_name": "ABIOMED INC DRN", "long_name": "Abiomed, Inc.", "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.", "currency": "BRL", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "SAO", "market": "br_market", "country": "United States", "city": "Danvers"}, "ABL.DE": {"short_name": "ABBOTT LABS", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "GER", "market": "de_market", "country": "United States", "city": "North Chicago"}, "ABMD": {"short_name": "ABIOMED, Inc.", "long_name": "Abiomed, Inc.", "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Danvers"}, "ABMD.MX": {"short_name": "ABIOMED INC", "long_name": "Abiomed, Inc.", "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Danvers"}, "ABMT": {"short_name": "ADVANCED BIOMEDICAL TECHNOLOGIE", "long_name": "Advanced Biomedical Technologies, Inc.", "summary": "Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, which include surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "New York"}, "ABT": {"short_name": "Abbott Laboratories", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "North Chicago"}, "ABT.BA": {"short_name": "ABBOTT LABS", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "ARS", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "BUE", "market": "ar_market", "country": "United States", "city": "North Chicago"}, "ABT.SN": {"short_name": "ABBOTT LABS", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "SGO", "market": "cl_market", "country": "United States", "city": "North Chicago"}, "ABT.SW": {"short_name": "ABBOTT LABOR", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "CHF", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "EBS", "market": "ch_market", "country": "United States", "city": "North Chicago"}, "ABTT34.SA": {"short_name": "ABBOTT      DRN", "long_name": "Abbott Laboratories", "summary": "Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; M\u00c3\u00a9ni\u00c3\u00a8re's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.", "currency": "BRL", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "SAO", "market": "br_market", "country": "United States", "city": "North Chicago"}, "ADMT": {"short_name": "ADM TRONICS UNLIMITED INC", "long_name": "ADM Tronics Unlimited, Inc.", "summary": "ADM Tronics Unlimited, Inc., together with its subsidiary, develops, manufactures, and sells electronics for non-invasive, electrotherapeutic, and diagnostic medical devices, veterinary, and other applications in the United States, Australia, Asia, and Europe. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. It also provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. In addition, the company offers water-based, adhesive, and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Further, it provides contract manufacturing services; and research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products. The company was founded in 1969 and is headquartered in Northvale, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Northvale"}, "AEMD": {"short_name": "Aethlon Medical, Inc.", "long_name": "Aethlon Medical, Inc.", "summary": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "San Diego"}, "AFIB": {"short_name": "Acutus Medical, Inc.", "long_name": "Acutus Medical, Inc.", "summary": "Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Carlsbad"}, "AFW.F": {"short_name": "ALIGN TECHNOLOGY DL-,0001", "long_name": "Align Technology, Inc.", "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in Tempe, Arizona.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Tempe"}, "AHCO": {"short_name": "AdaptHealth Corp.", "long_name": "AdaptHealth Corp.", "summary": "AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Plymouth Meeting"}, "AHPI": {"short_name": "Allied Healthcare Products, Inc", "long_name": "Allied Healthcare Products, Inc.", "summary": "Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers emergency medical products that include respiratory/resuscitation products, such as demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products that include spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was incorporated in 1979 and is headquartered in St. Louis, Missouri.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Saint Louis"}, "AIO.F": {"short_name": "ABIOMED INC.  DL-,01", "long_name": "Abiomed, Inc.", "summary": "Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Danvers"}, "ALGN": {"short_name": "Align Technology, Inc.", "long_name": "Align Technology, Inc.", "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in Tempe, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Tempe"}, "ALGN.MX": {"short_name": "ALIGN TECHNOLOGY INC", "long_name": "Align Technology, Inc.", "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in Tempe, Arizona.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Tempe"}, "ALGN.VI": {"short_name": "ALIGN TECHNOLOGY INC", "long_name": "Align Technology, Inc.", "summary": "Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in Tempe, Arizona.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VIE", "market": "at_market", "country": "United States", "city": "Tempe"}, "ALRT": {"short_name": "ALR TECHNOLOGIES INC", "long_name": "ALR Technologies Inc.", "summary": "ALR Technologies Inc. develops compliance monitoring systems that enable health care professionals to remotely monitor patient health conditions in the United States. The company's product includes Diabetes Management System, which consists of a communications software platform that enables health professionals to monitor the health progress of patients with diabetes. Its primary business markets are the providers of health insurance and the providers of disease and case management services, including the home care industry. The company was formerly known as Mo Betta Corp. and changed its name to ALR Technologies Inc. in December 1998. ALR Technologies Inc. was founded in 1987 and is headquartered in Richmond, Virginia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Richmond"}, "APEN": {"short_name": "Apollo Endosurgery, Inc.", "long_name": "Apollo Endosurgery, Inc.", "summary": "Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Austin"}, "APYX": {"short_name": "Apyx Medical Corporation", "long_name": "Apyx Medical Corporation", "summary": "Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Clearwater"}, "ARAY": {"short_name": "Accuray Incorporated", "long_name": "Accuray Incorporated", "summary": "Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Sunnyvale"}, "ATEC": {"short_name": "Alphatec Holdings, Inc.", "long_name": "Alphatec Holdings, Inc.", "summary": "Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Carlsbad"}, "AVGR": {"short_name": "Avinger, Inc.", "long_name": "Avinger, Inc.", "summary": "Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Redwood City"}, "AVH.AX": {"short_name": "AVITA MED CDI 5:1", "long_name": "AVITA Medical, Inc.", "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.", "currency": "AUD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASX", "market": "au_market", "country": "United States", "city": "Valencia"}, "AVHHL": {"short_name": "AVITA MEDICAL INC. CDI 5:1", "long_name": "AVITA Medical, Inc.", "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Valencia"}, "AVMR": {"short_name": "AVRA MED ROBOTICS INC", "long_name": "AVRA Medical Robotics, Inc.", "summary": "AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Orlando"}, "AVNS": {"short_name": "Avanos Medical, Inc.", "long_name": "Avanos Medical, Inc.", "summary": "Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Alpharetta"}, "AVTI": {"short_name": "AVITAR INC", "long_name": "Avitar, Inc.", "summary": "Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Canton"}, "AXGN": {"short_name": "AxoGen, Inc.", "long_name": "AxoGen, Inc.", "summary": "AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Alachua"}, "AXNX": {"short_name": "Axonics Modulation Technologies", "long_name": "Axonics Modulation Technologies, Inc.", "summary": "Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Irvine"}, "AXNX.MX": {"short_name": "AXONICS MODULATION TECHNLOGS IN", "long_name": "Axonics Modulation Technologies, Inc.", "summary": "Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Irvine"}, "AZYO": {"short_name": "Aziyo Biologics, Inc.", "long_name": "Aziyo Biologics, Inc.", "summary": "Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Silver Spring"}, "B5G2.F": {"short_name": "LATTICE BIOLOGICS LTD.", "long_name": "Lattice Biologics Ltd.", "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Belgrade"}, "BBLG": {"short_name": "BONE BIOLOGICS CORP", "long_name": "Bone Biologics Corporation", "summary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Burlington"}, "BIEL": {"short_name": "BIOELECTRONICS CORP", "long_name": "BioElectronics Corporation", "summary": "BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain relief; Smart Insole, a heel pain solution; Allay, a drug-free micro medical device that uses electromagnetic pulse therapy to reduce menstrual pain and discomfort; RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. The company sells its products to wholesale distributors, hospitals and clinics, and consumers. BioElectronics Corporation was founded in 2000 and is headquartered in Frederick, Maryland.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Frederick"}, "BIO": {"short_name": "Bio-Rad Laboratories, Inc.", "long_name": "Bio-Rad Laboratories, Inc.", "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Hercules"}, "BIO-B": {"short_name": "Bio-Rad Laboratories, Inc.", "long_name": "Bio-Rad Laboratories, Inc.", "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Hercules"}, "BIOL": {"short_name": "Biolase, Inc.", "long_name": "BIOLASE, Inc.", "summary": "BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Irvine"}, "BKD.F": {"short_name": "BRUKER CORP.  DL -,01", "long_name": "Bruker Corporation", "summary": "Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Billerica"}, "BOV.F": {"short_name": "APYX MEDICAL  DL-,001", "long_name": "Apyx Medical Corporation", "summary": "Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Clearwater"}, "BRKR": {"short_name": "Bruker Corporation", "long_name": "Bruker Corporation", "summary": "Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Billerica"}, "BRSF": {"short_name": "BRAIN SCIENTIFIC INC", "long_name": "Brain Scientific Inc.", "summary": "Brain Scientific Inc. operates as a neurodiagnostic and predictive technology platform company in the United States. The company provides a platform for data acquisition and analysis of electroencephalography (EEG) data that combines medical device technologies with cloud-based telehealth services. It offers NeuroCap, a disposable and soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional EEG systems; and NeuroEEG, a cloud-enabled data acquisition platform for electroencephalogram activity, as well as NeuroNet Cloud, a database where brain data can be stored and analyzed. The company also sells its products through online store, brainscientific.myshopify.com. Brain Scientific Inc. was founded in 2015 and is headquartered in Bohemia, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Bohemia"}, "BSGM": {"short_name": "BioSig Technologies, Inc.", "long_name": "BioSig Technologies, Inc.", "summary": "BioSig Technologies, Inc., a medical device company, engages in developing and commercializing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. The company's proprietary product include precise uninterrupted real-time evaluation of electrograms electrophysiology system, a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures in an electrophysiology laboratory under the supervision of licensed healthcare practitioners who are responsible for interpreting the data. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases. BioSig Technologies, Inc. was founded in 2009 and is headquartered in Westport, Connecticut.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Westport"}, "BTCY": {"short_name": "BIOTRICITY INC", "long_name": "Biotricity, Inc.", "summary": "Biotricity, Inc., medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG readings in preventative healthcare applications; and a strategic partnership with Verizon to develop EMS solutions for first responders by integrating its Bioflux solution. The company is based in Redwood City, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Redwood City"}, "BTH1.F": {"short_name": "BIOLASE INC.  DL -,001", "long_name": "BIOLASE, Inc.", "summary": "BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Irvine"}, "BUW.F": {"short_name": "BIO-RAD LABS INC. B  DL 1", "long_name": "Bio-Rad Laboratories, Inc.", "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Hercules"}, "BUWA.DE": {"short_name": "BIO-RAD LABS INC.DL-,0001", "long_name": "Bio-Rad Laboratories, Inc.", "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "GER", "market": "de_market", "country": "United States", "city": "Hercules"}, "BUWA.F": {"short_name": "BIO-RAD LABS INC.DL-,0001", "long_name": "Bio-Rad Laboratories, Inc.", "summary": "Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the United States, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Hercules"}, "CFMS": {"short_name": "Conformis, Inc.", "long_name": "Conformis, Inc.", "summary": "Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Billerica"}, "CGHC": {"short_name": "CAPITAL GROUP HOLDINGS INC", "long_name": "Capital Group Holdings, Inc.", "summary": "Capital Group Holdings, Inc. provides health and wellness products and services in the United States. The company provides OneHealthPass, a Web-based personal health record system, which allows documents, images, and voice mail messages to be transmitted in and out of the system using various methods, including fax, voice, and file upload. It also offers patient-centric telehealth services; and operates 7 urgent care clinics located in the Phoenix, Arizona Metropolitan Area, that provide medical care services. The company was formerly known as Oasis Online Technologies, Corp. and changed its name to Capital Group Holdings, Inc. in April, 2010. Capital Group Holdings, Inc. was incorporated in 1980 and is based in Scottsdale, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Scottsdale"}, "CHFS": {"short_name": "CHF Solutions, Inc.", "long_name": "CHF Solutions, Inc.", "summary": "CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. The company's commercial product is the Aquadex FlexFlow System, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in the United Kingdom, Italy, Spain, Germany, Austria, Switzerland, Southeast Asia, Brazil, India, and Greece. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Eden Prairie"}, "CLPT": {"short_name": "ClearPoint Neuro Inc.", "long_name": "ClearPoint Neuro, Inc.", "summary": "ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for insertion of catheters, electrodes, and laser fibers to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The company has a license agreements with The Johns Hopkins University; development agreement with Mayo Clinic to design and develop MRI-guided therapies for stroke; and a collaborative license and co-development agreement with Clinical Laserthermia Systems AB. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was founded in 1998 and is headquartered in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Irvine"}, "CNMD": {"short_name": "CONMED Corporation", "long_name": "CONMED Corporation", "summary": "CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Utica"}, "CNMD.MX": {"short_name": "CONMED CORP", "long_name": "CONMED Corporation", "summary": "CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Utica"}, "CRY": {"short_name": "CryoLife, Inc.", "long_name": "CryoLife, Inc.", "summary": "CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products, a range of stent graft systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G, a stent graft system for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers vascular preservation services; synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products, such as YAG laser consoles, related service and maintenance, and single-use, fiber-optic handpieces; and CryoVein femoral vein and CryoArtery femoral artery vascular preservation services for vascular access. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Kennesaw"}, "CSII": {"short_name": "Cardiovascular Systems, Inc.", "long_name": "Cardiovascular Systems, Inc.", "summary": "Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Saint Paul"}, "CSSI": {"short_name": "COSTAS INC", "long_name": "Costas, Inc.", "summary": "Costas, Inc., a digital media company, owns and develops Web-based consumer Internet assets and communities in the United States and India. It operates ejobresource.com, an online job portal that offers recruitment and placement services. The company also provides under graduate and graduate degree courses; and systems integration and software services. It serves the media and entertainment, agency, retail, manufacturing, financial services, and various other industries. The company was founded in 1998 and is based in Tempe, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Tempe"}, "CTSO": {"short_name": "Cytosorbents Corporation", "long_name": "Cytosorbents Corporation", "summary": "Cytosorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The company's flagship product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; adjunctive therapy in other critical care applications; prevention and treatment of post-operative complications of cardiopulmonary bypass surgery; prevention and treatment of organ dysfunction in brain-dead organ donors to increase the number and quality of viable organs harvested from donors; and VetResQ device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients; K+ontrol for treatment of severe hyperkalemia with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, a development-stage extracorporeal hemoperfusion cartridge designed to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to CytoSorbents Corporation in May 2010. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Monmouth Junction"}, "CTTC": {"short_name": "CALMARE THERAPEUTICS INC", "long_name": "Calmare Therapeutics Incorporated", "summary": "Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Fairfield"}, "CUTR": {"short_name": "Cutera, Inc.", "long_name": "Cutera, Inc.", "summary": "Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Brisbane"}, "CYDX": {"short_name": "CYDUCT DIAGNOSTICS INC", "long_name": "CYduct Diagnostics, Inc.", "summary": "CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Boston"}, "CYL.F": {"short_name": "CRYOLIFE INC.  DL-,01", "long_name": "CryoLife, Inc.", "summary": "CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products, a range of stent graft systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G, a stent graft system for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers vascular preservation services; synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products, such as YAG laser consoles, related service and maintenance, and single-use, fiber-optic handpieces; and CryoVein femoral vein and CryoArtery femoral artery vascular preservation services for vascular access. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Kennesaw"}, "DCTH": {"short_name": "Delcath Systems, Inc.", "long_name": "Delcath Systems, Inc.", "summary": "Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company's lead product candidate is the melphalan hydrochloride for injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its Phase III clinical trial products include FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial for intrahepatic cholangiocarcinoma. The company also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "New York"}, "DYNT": {"short_name": "Dynatronics Corporation", "long_name": "Dynatronics Corporation", "summary": "Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Eagan"}, "DYXA.SG": {"short_name": "Dynatronics Corp. Registered Sh", "long_name": "Dynatronics Corporation", "summary": "Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company also provides power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, recumbent bikes, and other related equipment. In addition, it offers therapeutic modality devices, such as electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. Further, the company provides clinical supplies, including exercise bands and tubing, topical analgesics, lotions and gels, orthopedic bracing, paper products, athletic tapes, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, and athletic trainers, sports medicine practitioners, hospitals, clinics, and consumers, as well as online. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Eagan, Minnesota.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "STU", "market": "dr_market", "country": "United States", "city": "Eagan"}, "E2OM.F": {"short_name": "STRATA SKIN SCIENC.DL-,01", "long_name": "STRATA Skin Sciences, Inc.", "summary": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Horsham"}, "EAR": {"short_name": "Eargo, Inc.", "long_name": "Eargo, Inc.", "summary": "Eargo, Inc., a consumer-focused medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "San Jose"}, "EC8.F": {"short_name": "CONMED CORP.  DL-,01", "long_name": "CONMED Corporation", "summary": "CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Utica"}, "ECGI": {"short_name": "EVENT CARDIO GROUP INC", "long_name": "ECGI Holdings, Inc.", "summary": "ECGI Holdings, Inc., through its subsidiary, operates in the cardiac medical device innovation, patient monitoring, and cardiac event prediction industry. The company is developing cardiac monitoring device based on a wireless and leadless advance cardiac monitor. Its products include Now Cardio, a cardiac monitor that offers dual-functionality, including holter monitoring and event recording. The company was formerly known as Event Cardio Group Inc. and changed its name to ECGI Holdings, Inc. in August 2019. ECGI Holdings, Inc. is based in Los Angeles, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Los Angeles"}, "ECTE": {"short_name": "ECHO THERAPEUTICS INC", "long_name": "Echo Therapeutics, Inc.", "summary": "Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. In addition, it has a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell CGM to medical facilities and individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd to research, develop, manufacture, and use CGM in the People's Republic of China, Hong Kong, Macau, and Taiwan. The company was founded in 1989 and is headquartered in Iselin, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Iselin"}, "EJU.F": {"short_name": "AETHLON MEDIC.NEW DL-,001", "long_name": "Aethlon Medical, Inc.", "summary": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "San Diego"}, "ELMD": {"short_name": "Electromed, Inc.", "long_name": "Electromed, Inc.", "summary": "Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASE", "market": "us_market", "country": "United States", "city": "New Prague"}, "EMED": {"short_name": "ELECTROMEDICAL TECHNOLOGIES INC", "long_name": "Electromedical Technologies, Inc.", "summary": "Electromedical Technologies, Inc. develops bioelectronic medicine therapy device. The company's products include WellnessPro Plus which is used to treat chronic and acute pain. Electromedical Technologies, Inc. was founded in 2007 and is headquartered in Scottsdale, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Scottsdale"}, "ENCW": {"short_name": "ENCHANTED WORLD INC", "long_name": "Enchanted World Inc.", "summary": "Enchanted World Inc. engages in the development, manufacture, and distribution of health care products in the United States. The company offers fitness and weight loss equipment and products. The company offers BioFit infrared bike, a design for the use of infrared and exercise to reduce body fat. The BioFit engages 3,300 watts of infrared lights and offers detox, inch loss, weight loss, inflammation reduction, pain control, and enhanced calorie burn. It provides its products to wellness and weight loss centers, med spas, gyms, doctors' offices, and day spas. The company was formerly known as Cardio Infrared Technologies, Inc. and changed its name to Enchanted World Inc. in December 2014. Enchanted World Inc. is based in Henderson, Nevada.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Henderson"}, "ENDY.TA": {"short_name": "ENDYMED LTD", "long_name": "Endymed Ltd", "summary": "Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, body contouring, texture enhancement, cellulite reduction, circumferential reduction, acne and acne scar reduction, stretch mark reduction, RF micro needling, and fractional resurfacing. The company was founded in 2007 and is based in Freehold, New Jersey.", "currency": "ILA", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "TLV", "market": "il_market", "country": "United States", "city": "Freehold"}, "EQUR": {"short_name": "E-QURE CORP", "long_name": "E-Qure Corp.", "summary": "E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers down to complete closure and/or cure. E-Qure Corp. is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "New York"}, "ESMC": {"short_name": "ESCALON MEDICAL CORP", "long_name": "Escalon Medical Corp.", "summary": "Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. The company also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; distributes intraocular gas products, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and manufactures and distributes a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it offers disposable surgical packs that are used in vitreoretinal surgery; viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; and AXIS Image management system for managing images through the Web browser from various devices regardless of modality, manufacturer, or location. The company sells its products to medical institutions through independent sales representatives, a network of distributors, and internal sales employees. Escalon Medical Corp. was founded in 1987 and is headquartered in Wayne, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Wayne"}, "EW": {"short_name": "Edwards Lifesciences Corporatio", "long_name": "Edwards Lifesciences Corporation", "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Irvine"}, "EW.MX": {"short_name": "EDWARDS LIFESCIENCES CORP", "long_name": "Edwards Lifesciences Corporation", "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Irvine"}, "EWL.DE": {"short_name": "EDWARDS LIFESCIENCES", "long_name": "Edwards Lifesciences Corporation", "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "GER", "market": "de_market", "country": "United States", "city": "Irvine"}, "EWL.F": {"short_name": "EDWARDS LIFESCIENCES", "long_name": "Edwards Lifesciences Corporation", "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Irvine"}, "EWLS.VI": {"short_name": "EDWARDS LIFESCIENCES CORP", "long_name": "Edwards Lifesciences Corporation", "summary": "Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VIE", "market": "at_market", "country": "United States", "city": "Irvine"}, "EYES": {"short_name": "Second Sight Medical Products, ", "long_name": "Second Sight Medical Products, Inc.", "summary": "Second Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Sylmar"}, "FOAA.F": {"short_name": "FONAR CORP. NEW  DL-,0001", "long_name": "FONAR Corporation", "summary": "FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates four diagnostic imaging facilities in Florida; and manages 35 MRI scanning facilities, including 22 facilities located in New York and 13 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Melville"}, "FONR": {"short_name": "Fonar Corporation", "long_name": "FONAR Corporation", "summary": "FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates four diagnostic imaging facilities in Florida; and manages 35 MRI scanning facilities, including 22 facilities located in New York and 13 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Melville"}, "GBS": {"short_name": "GBS Inc.", "long_name": "GBS Inc.", "summary": "GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "New York"}, "GHST": {"short_name": "GHOST TECHNOLOGY INC", "long_name": "Ghost Technology Inc", "summary": "Ghost Technology Inc inserts directly or indirectly, assets in business, investment banks, real estate, green economies, sponsors, fashion, movie, sports, this to have a total diversification to increase capitalization and revenues, and reduce as much as possible the risks of the investments. The company was formerly known as I.A. Europe Group, Inc. and changed its name to Ghost Technology Inc in April 2008. Ghost Technology Inc was founded in 1999 and is headquartered in New York, New York. Ghost Technology Inc operates as a subsidiary of I.A. Europe, Inc.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "New York"}, "GM0N.F": {"short_name": "GLOBUS MED.A NEW DL -,001", "long_name": "Globus Medical, Inc.", "summary": "Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Audubon"}, "GMED": {"short_name": "Globus Medical, Inc.", "long_name": "Globus Medical, Inc.", "summary": "Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Audubon"}, "GMED.MX": {"short_name": "GLOBUS MED INC", "long_name": "Globus Medical, Inc.", "summary": "Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Audubon"}, "GNF.F": {"short_name": "GENMARK DIAGNOST.DL-,0001", "long_name": "GenMark Diagnostics, Inc.", "summary": "GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Carlsbad"}, "GNMK": {"short_name": "GenMark Diagnostics, Inc.", "long_name": "GenMark Diagnostics, Inc.", "summary": "GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular panels based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Carlsbad"}, "GTHP": {"short_name": "GUIDED THERAPEUTICS INC", "long_name": "Guided Therapeutics, Inc.", "summary": "Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Norcross"}, "HCYT": {"short_name": "H CYTE INC", "long_name": "H-CYTE, Inc.", "summary": "H-CYTE, Inc., a medical biosciences company, develops and implements various treatment options in regenerative medicine to treat chronic lung diseases. It engages in the development of L-CYTE-01 for the treatment of chronic obstructive pulmonary diseases. The company is headquartered in Tampa, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Tampa"}, "HJLI": {"short_name": "Hancock Jaffe Laboratories, Inc", "long_name": "Hancock Jaffe Laboratories, Inc.", "summary": "Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It develops and manufactures bioprosthetic implantable devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. operates as a subsidiary of Leman Cardiovascular SA.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Irvine"}, "HQ8F.F": {"short_name": "APOLLO ENDOSURGERY DL-,01", "long_name": "Apollo Endosurgery, Inc.", "summary": "Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Austin"}, "HRTT": {"short_name": "HEART TRONICS INC", "long_name": "Heart Tronics, Inc.", "summary": "Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Studio City"}, "HSM.TO": {"short_name": "HELIUS MEDICAL TECHNOLOGIES INC", "long_name": "Helius Medical Technologies, Inc.", "summary": "Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "TOR", "market": "ca_market", "country": "United States", "city": "Newtown"}, "HTL.V": {"short_name": "HAMILTON THORNE LTD", "long_name": "Hamilton Thorne Ltd.", "summary": "Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers laser products used in a range of scientific applications and in vitro fertilization (IVF) procedures; and image analysis systems used in the studies of reproductive cells in the human fertility, animal sciences, and reproductive toxicology fields. The company also provides micromanipulation systems that assists the embryologist in performing critical procedures in the IVF lab under the TrakJector brand; a line of air filtration products to enhance air quality in the laboratory under the ZANDAIR brand; incubators, control rate freezers, and lab monitoring systems for the ART and cell biology markets under the Planer brand; and reproductive medicine, including clinical and laboratory equipment, and disposables, as well as installations of ART clinics under the Gynemed brand. In addition, it offers GM501 family of products, which provides the IVF lab with a range of cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation; quality control assays used in IVF labs for testing equipment and materials' toxicity under the Embryotech brand; and glass micropipettes. Further, the company provides equipment service contract and maintenance programs; quality control testing services to manufacturers of medical devices, culture media, and consumables used in IVF labs; and laboratory design and installation services. Additionally, it distributes a range of specialized equipment, software, accessories, and consumables. The company sells its products through direct sales force and distributors to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VAN", "market": "ca_market", "country": "United States", "city": "Beverly"}, "IART": {"short_name": "Integra LifeSciences Holdings C", "long_name": "Integra LifeSciences Holdings Corporation", "summary": "Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it sells hardware products, such as bone and joint fixation, and joint replacement devices; and implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Princeton, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Princeton"}, "IGNT": {"short_name": "INGEN TECHNOLOGIES INC", "long_name": "Ingen Technologies, Inc.", "summary": "Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. The company manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease; and oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark name. Its Oxyview is a pneumatic metering device that displays and confirms the oxygen flow rate near the patient. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Riverside"}, "IKMA": {"short_name": "INTELAKARE MARKETING INC", "long_name": "IntelaKare Marketing, Inc.", "summary": "IntelaKare Marketing, Inc. provides online retail services for food products and home appliances. The company is based in Citra, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Citra"}, "IMR.AX": {"short_name": "IMRICOR CDI FORUS", "long_name": "Imricor Medical Systems, Inc.", "summary": "Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States and Europe. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was founded in 2006 and is headquartered in Burnsville, Minnesota.", "currency": "AUD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASX", "market": "au_market", "country": "United States", "city": "Burnsville"}, "INGN": {"short_name": "Inogen, Inc", "long_name": "Inogen, Inc.", "summary": "Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Goleta"}, "INLB": {"short_name": "ITEM 9 LABS CORP", "long_name": "Item 9 Labs Corp.", "summary": "Item 9 Labs Corp. produces cannabis and cannabis-related products in the United States. It offers products in various categories, such as flower; concentrates; distillates; and hardware. The company provides medical cannabis strains, shatter, crumble, badder, THCA, Delta 8 THC, broad spectrum distillate, and live resin terpene sauce. It offers products through licensed dispensaries to consumers in Arizona. The company is headquartered in Phoenix, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Phoenix"}, "INSP": {"short_name": "Inspire Medical Systems, Inc.", "long_name": "Inspire Medical Systems, Inc.", "summary": "Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Golden Valley"}, "INVO": {"short_name": "INVO BioScience, Inc.", "long_name": "INVO Bioscience, Inc.", "summary": "INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. The company offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development; and INVOcell Retention device, a single-use modified diaphragm that includes holes to allow for natural drainage of vaginal fluids to aid in retention of the INVOcell device in the vaginal cavity during the incubation period. It also provides fixed laboratory equipment comprising microscopes with video systems, bench centrifuges, incubators without CO2, bench warmers, and laminar flow hoods. The company sells its products to physicians and IVF centers. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Sarasota"}, "IRIX": {"short_name": "IRIDEX Corporation", "long_name": "IRIDEX Corporation", "summary": "IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Mountain View"}, "IRMD": {"short_name": "iRadimed Corporation", "long_name": "IRadimed Corporation", "summary": "IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Winter Springs"}, "ITGR": {"short_name": "Integer Holdings Corporation", "long_name": "Integer Holdings Corporation", "summary": "Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac and neuromodulation products, such as batteries, capacitors, filtered feedthroughs, and implantable leads; implanted medical devices, pacemakers, implantable cardioverter defibrillators, implantable cardiac pacing and defibrillation leads, and heart failure therapies, such as ventricular assist devices and cardiac resynchronization devices. In addition, the company offers rechargeable batteries and chargers, and non-rechargeable batteries; arthroscopic devices and components, including shaver blades and burrs, ablation probes, and suture anchors; and laparoscopic and general surgery products, such as harmonic scalpels, radio frequency probes, and ophthalmic surgery devices. Further, it provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Plano"}, "IV3.F": {"short_name": "INVACARE CORP.", "long_name": "Invacare Corporation", "summary": "Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and K\u00c3\u00bcschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Elyria"}, "IVC": {"short_name": "Invacare Corporation", "long_name": "Invacare Corporation", "summary": "Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and K\u00c3\u00bcschall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators; and Invacare HomeFill oxygen systems. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Elyria"}, "IX4.F": {"short_name": "IRIDEX CORP.  DL-,01", "long_name": "IRIDEX Corporation", "summary": "IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Mountain View"}, "KIDS": {"short_name": "OrthoPediatrics Corp.", "long_name": "OrthoPediatrics Corp.", "summary": "OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, and QuickPack. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Warsaw"}, "KLYG": {"short_name": "KELYNIAM GLOBAL INC", "long_name": "Kelyniam Global, Inc.", "summary": "Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers. The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, and health systems and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was founded in 2005 and is based in Collinsville, Connecticut.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Collinsville"}, "LBL.V": {"short_name": "LATTICE BIOLOGICS LTD", "long_name": "Lattice Biologics Ltd.", "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. The company offers AmnioBoost, an allograft amniotic fluid visco supplement for the treatment of joint pain associated with osteoarthritis, as well as traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VAN", "market": "ca_market", "country": "United States", "city": "Belgrade"}, "LBLTF": {"short_name": "LATTICE BIOLOGICS LTD", "long_name": "Lattice Biologics Ltd.", "summary": "Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. The company offers AmnioBoost, an allograft amniotic fluid visco supplement for the treatment of joint pain associated with osteoarthritis, as well as traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Belgrade"}, "LCDX": {"short_name": "CALIBER IMAGING & DIAGNOSTICS I", "long_name": "Caliber Imaging & Diagnostics, Inc.", "summary": "Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Andover"}, "LLBO": {"short_name": "LIFELINE BIOTECHNOLOGIES INC", "long_name": "Lifeline Biotechnologies, Inc.", "summary": "Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Reno"}, "LNSR": {"short_name": "LENSAR, Inc.", "long_name": "LENSAR, Inc.", "summary": "LENSAR, Inc. operates as a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Orlando"}, "LPTI": {"short_name": "LONGPORT INC", "long_name": "Longport, Inc.", "summary": "Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, clinical dermatology, and aesthetics/plastics, as well as in various other applications, including burn assessment, superficial musculoskeletal imaging, and veterinary applications. It also exports its products. The company was founded in 1993 and is based in Chadds Ford, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Chadds Ford"}, "LT3.F": {"short_name": "AXOGEN INC.  DL -,01", "long_name": "AxoGen, Inc.", "summary": "AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Alachua"}, "LUNG": {"short_name": "Pulmonx Corporation", "long_name": "Pulmonx Corporation", "summary": "Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Redwood City"}, "LXG.V": {"short_name": "LEXAGENE HOLDINGS INC", "long_name": "LexaGene Holdings Inc.", "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VAN", "market": "ca_market", "country": "United States", "city": "Beverly"}, "LXXGF": {"short_name": "LEXAGENE HOLDINGS INC", "long_name": "LexaGene Holdings Inc.", "summary": "LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated genetic analyzers for pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company is headquartered in Beverly, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Beverly"}, "MASS": {"short_name": "908 Devices Inc.", "long_name": "908 Devices Inc.", "summary": "908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was founded in 2012 and is headquartered in Boston, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Boston"}, "MDXG": {"short_name": "MiMedx Group, Inc", "long_name": "MiMedx Group, Inc.", "summary": "MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, arterial ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill, a connective tissue matrix derived from placental disc, umbilical cord, and amnion/chorion tissues. Its products have applications in the areas of wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. The company sells its products through direct sales force, independent sales agents, and third party representatives, as well as independent distributors. MiMedx Group, Inc. is headquartered in Marietta, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Marietta"}, "MFST": {"short_name": "MEDIFIRST SOLUTIONS INC", "long_name": "Medifirst Solutions, Inc", "summary": "Medifirst Solutions, Inc., a development stage company, focuses on developing products within the healthcare market for consumer and professional applications. It develops a hand-held mobile laser system, The Time Machine Series lasers to treat temporary relief of minor muscle and joint pains, stiffness, minor arthritis pain, muscle spasms, temporary increase in local blood circulation, and temporary relaxation of muscles. Medifirst Solutions, Inc. was founded in 2010 and is based in Freehold, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Freehold"}, "MHTX": {"short_name": "MANHATTAN SCIENTIFICS INC", "long_name": "Manhattan Scientifics, Inc.", "summary": "Manhattan Scientifics, Inc., a technology incubator, develops and commercializes life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "New York"}, "MICR": {"short_name": "MICRON SOLUTIONS INC", "long_name": "Micron Solutions, Inc.", "summary": "Micron Solutions, Inc., through its subsidiary, Micron Products, Inc., operates as a contract manufacturing organization that produces medical device components requiring precision machining and injection molding in the United States and internationally. The company also manufactures components, devices, and equipment for military, law enforcement, automotive, and consumer product applications. Its products include silver/silver chloride coated and conductive resin sensors for use as consumable component parts in integrated disposable electrophysiological sensors that are used in monitoring electrical signals in various medical applications. The company also offers orthopedic implant components; thermoplastic injection molding services; and value added services, including the design, manufacture, and rehabilitation of injection molding tools. It serves original equipment manufacturers, and other contract manufacturing organizations, as well as defense industries. The company was formerly known as Arrhythmia Research Technology, Inc. and changed its name to Micron Solutions, Inc. in March 2017. Micron Solutions, Inc. is based in Fitchburg, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Fitchburg"}, "MMTC": {"short_name": "MICRO IMAGING TECH INC", "long_name": "Micro Imaging Technology, Inc.", "summary": "Micro Imaging Technology, Inc., a development stage company, engages in the development of fluid monitoring systems for water monitoring, food processing, and clinical applications in the United States. The company is developing a non-biologically based system utilizing both proprietary hardware and software to determine the specific specie of an unknown microbe present in a fluid with a high degree of statistical probability. It would analyze a sample presented to it and compares its characteristics to a library of known microbe characteristics on file. The company was formerly known as Electropure, Inc. and changed its name to Micro Imaging Technology, Inc. in November 2005. Micro Imaging Technology, Inc. was founded in 1979 and is headquartered in San Clemente, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Clemente"}, "MODD": {"short_name": "MODULAR MEDICAL INC", "long_name": "Modular Medical, Inc.", "summary": "Modular Medical, Inc., a development stage medical device company, focuses on design, development, and commercialization of insulin pumps for insulin dependent people with diabetes. Its hardware technology allows people with diabetes to receive their daily insulin through continuous basal delivery and bolus delivery. The company is based in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Diego"}, "MPM.F": {"short_name": "MICRON SOLUTIONS  DL-,001", "long_name": "Micron Solutions, Inc.", "summary": "Micron Solutions, Inc., through its subsidiary, Micron Products, Inc., operates as a contract manufacturing organization that produces medical device components requiring precision machining and injection molding in the United States and internationally. The company also manufactures components, devices, and equipment for military, law enforcement, automotive, and consumer product applications. Its products include silver/silver chloride coated and conductive resin sensors for use as consumable component parts in integrated disposable electrophysiological sensors that are used in monitoring electrical signals in various medical applications. The company also offers orthopedic implant components; thermoplastic injection molding services; and value added services, including the design, manufacture, and rehabilitation of injection molding tools. It serves original equipment manufacturers, and other contract manufacturing organizations, as well as defense industries. The company was formerly known as Arrhythmia Research Technology, Inc. and changed its name to Micron Solutions, Inc. in March 2017. Micron Solutions, Inc. is based in Fitchburg, Massachusetts.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Fitchburg"}, "MSON": {"short_name": "MISONIX, Inc.", "long_name": "Misonix, Inc.", "summary": "Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Farmingdale"}, "MX9.F": {"short_name": "MISONIX INC.  DL-,01", "long_name": "Misonix, Inc.", "summary": "Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Farmingdale"}, "MYO": {"short_name": "Myomo Inc.", "long_name": "Myomo, Inc.", "summary": "Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient's weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASE", "market": "us_market", "country": "United States", "city": "Cambridge"}, "MZEIQ": {"short_name": "MEDIZONE INTERNATIONAL", "long_name": "Medizone International, Inc.", "summary": "Medizone International, Inc. develops, manufactures, and sells disinfection systems in the United States and internationally. It offers AsepticSure system, a disinfection system that is used in medical facilities, such as hospitals, clinics, physician's offices, outpatient surgical centers, and long-term care facilities; food industry; bio-safety labs; athletic facilities, such as gyms and locker rooms, as well as sports equipment; and mortuaries, bio-defense and response to pandemics, building remediation, tissue labs, sporting venues, and hotels, as well as clean rooms to disinfect hard and non-porous surfaces. The company was founded in 1986 and is based in Kalamazoo, Michigan. On May 8, 2018, Medizone International, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of Nevada.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Kalamazoo"}, "NAOV": {"short_name": "NanoVibronix, Inc.", "long_name": "NanoVibronix, Inc.", "summary": "NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Elmsford"}, "NARI": {"short_name": "Inari Medical, Inc.", "long_name": "Inari Medical, Inc.", "summary": "Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Irvine"}, "NEMD": {"short_name": "INEEDMD HLDGS INC", "long_name": "iNeedMD Holdings, Inc.", "summary": "iNeedMD Holdings, Inc., a medical device development company, researches, develops, markets, and sells medical devices in the United States and internationally. The company offers The EKG Glove, a disposable medical device that is used in the diagnosis, screening, prevention, and monitoring of cardiovascular diseases. Its product has applications in hospitals, nursing homes and skilled nursing facilities, medical transportation, remote medical assessment, urgent care health clinics, and heart rhythm monitoring. iNeedMD Holdings, Inc. is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "New York"}, "NK8.F": {"short_name": "NUVASIVE INC.  DL-,001", "long_name": "NuVasive, Inc.", "summary": "NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "San Diego"}, "NM4.F": {"short_name": "NATUS MEDICAL INC. DL-001", "long_name": "Natus Medical Incorporated", "summary": "Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders; head-cooling products for the treatment of brain injury in newborns; and incubators to control the newborn's environment. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, and governmental agencies. The company was founded in 1987 and is headquartered in Pleasanton, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Pleasanton"}, "NMRD": {"short_name": "Nemaura Medical Inc.", "long_name": "Nemaura Medical Inc.", "summary": "Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; the Why WAIT app; and common law trademarks which incorporate the mark WHY WAIT or WHYWAIT and the use of licensed marks. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "New York"}, "NMTC": {"short_name": "NEUROONE MEDICAL TECHNOLOGIES C", "long_name": "NeuroOne Medical Technologies Corporation", "summary": "NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. The company is based in Eden Prairie, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Eden Prairie"}, "NTUS": {"short_name": "Natus Medical Incorporated", "long_name": "Natus Medical Incorporated", "summary": "Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders; head-cooling products for the treatment of brain injury in newborns; and incubators to control the newborn's environment. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, and governmental agencies. The company was founded in 1987 and is headquartered in Pleasanton, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Pleasanton"}, "NUMD": {"short_name": "NU-MED PLUS INC", "long_name": "Nu-Med Plus, Inc.", "summary": "Nu-Med Plus, Inc., a medical device company, engages in the design, development, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Salt Lake City"}, "NUVA": {"short_name": "NuVasive, Inc.", "long_name": "NuVasive, Inc.", "summary": "NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "San Diego"}, "NUVA.MX": {"short_name": "NUVASIVE INC", "long_name": "NuVasive, Inc.", "summary": "NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "San Diego"}, "NVRO": {"short_name": "Nevro Corp.", "long_name": "Nevro Corp.", "summary": "Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. It also offers Senza II system and Senza Omnia system products for chronic pain. The company's solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro Corp. sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was founded in 2006 and is headquartered in Redwood City, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Redwood City"}, "NWCI": {"short_name": "NEWCARDIO INC", "long_name": "NewCardio, Inc.", "summary": "NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Branchburg"}, "NXNN": {"short_name": "NEXEON MEDSYSTEMS INC", "long_name": "Nexeon MedSystems Inc.", "summary": "Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Dallas"}, "OCLG": {"short_name": "ONCOLOGIX TECH INC", "long_name": "Oncologix Tech, Inc.", "summary": "Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Lafayette"}, "ODYY": {"short_name": "ODYSSEY GROUP INTL INC", "long_name": "Odyssey Group International, Inc.", "summary": "Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Irvine"}, "OFIX": {"short_name": "Orthofix Medical Inc.", "long_name": "Orthofix Medical Inc.", "summary": "Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion as well as used as a therapeutic treatment for non-spinal appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Lewisville"}, "OM": {"short_name": "Outset Medical, Inc.", "long_name": "Outset Medical, Inc.", "summary": "Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo, a dialysis machine that enables dialysis care in acute and chronic settings. The Tablo comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "San Jose"}, "OMRX": {"short_name": "ORTHOMETRIX INC", "long_name": "Orthometrix, Inc.", "summary": "Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public. The company offers bone and muscle diagnostic, bone and muscle research, rehabilitation/physical therapy, sports and fitness, and home products. It serves healthcare, veterinary, and sports and fitness markets in the United States and internationally. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Naples"}, "OSP.AX": {"short_name": "OSPREY MED CDI FORUS", "long_name": "Osprey Medical, Inc.", "summary": "Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies. The company focuses on protecting patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert NG, DyeVert Plus System, and DyeVert Plus EZ Systems, which are used to reduce contrast injected into patients during standard cardiovascular and peripheral procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.", "currency": "AUD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASX", "market": "au_market", "country": "United States", "city": "Minnetonka"}, "PAVM": {"short_name": "PAVmed Inc.", "long_name": "PAVmed Inc.", "summary": "PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "New York"}, "PBIO": {"short_name": "PRESSURE BIOSCIENCES INC", "long_name": "Pressure BioSciences, Inc.", "summary": "Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions in North America, Europe, and Asia. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as pressure used to lyse samples for extraction tubes and other processing tubes, as well as application specific kits, including consumable products and reagents. It serves government institutions, pharmaceutical and biotechnology companies, and academic laboratories. Pressure BioSciences, Inc. has a collaboration with The Steinbeis Centre for biopolymer analysis and biomedical mass spectrometry; and NutraLife Biosciences for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "South Easton"}, "PECN": {"short_name": "PHOTOELECTRON CORP", "long_name": "Photoelectron Corp.", "summary": "Photoelectron Corporation, a technology company, engages in the development, manufacture, and marketing of miniature x-ray systems for multiple market applications. It creates and adapts miniature x-ray systems for various applications in healthcare and nonhealthcare related markets. The company offers micro-adaptive x-ray systems designed for x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, intraoperative radiation therapy, and instrumentation to the industrial and medical markets through original equipment manufacturers. Photoelectron Corporation was founded in 1989 and is based in North Billerica, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "North Billerica"}, "PEN": {"short_name": "Penumbra, Inc.", "long_name": "Penumbra, Inc.", "summary": "Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Alameda"}, "PEN.MX": {"short_name": "PENUMBRA INC", "long_name": "Penumbra, Inc.", "summary": "Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Alameda"}, "PETVD": {"short_name": "PETVIVO HLDGS INC", "long_name": "PetVivo Holdings, Inc.", "summary": "PetVivo Holdings, Inc., a biomedical device company, engages in the licensing and commercializing medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products includes 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Minneapolis"}, "PGUZ": {"short_name": "PEGASUS PHARMACEUTICALS INC", "long_name": "Pegasus Pharmaceuticals Inc.", "summary": "Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Palm Beach Gardens"}, "PLLWF": {"short_name": "POLAREAN IMAGING PLC", "long_name": "Polarean Imaging plc", "summary": "Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is headquartered in Durham, North Carolina.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Durham"}, "PMDL": {"short_name": "PACE MEDICAL INC", "long_name": "Pace Medical, Inc.", "summary": "Pace Medical, Inc. designs and markets cardiac pacing products for medical professions in the United States and internationally. The company offers Model 4580 MICRO-PACE, a programmable and dual-chamber temporary cardiac pacemaker for multi-mode and multi-parameter operation; Model EV4543, a single-chamber temporary cardiac pacemaker that is designed to provide acute therapeutic, prophylactic, and diagnostic pacing support; and The Bedside Model 4170, a single-chamber temporary cardiac pacemaker. It also provides REF 4800 pacing analyzer, an internally powered and software-programmable device designed for continuous operation in the acute cardiac-care environment as temporary cardiac pacemaker and a pacing analyzer; and autoclavable and single-use surgical/patient extension cables and adapters. The company was founded in 1985 and is based in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Diego"}, "PODD": {"short_name": "Insulet Corporation", "long_name": "Insulet Corporation", "summary": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Its Omnipod System comprise two devices: a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, and its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Acton"}, "POLX.L": {"short_name": "POLAREAN IMAGING PLC ORD GBP0.0", "long_name": "Polarean Imaging plc", "summary": "Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is headquartered in Durham, North Carolina.", "currency": "GBp", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "LSE", "market": "gb_market", "country": "United States", "city": "Durham"}, "POSC": {"short_name": "POSITRON CORP", "long_name": "Positron Corporation", "summary": "Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers PET molecular imaging systems, clinical and support services, automated radiopharmaceutical systems, and radiopharmaceuticals and radioisotope processing and production. The company's Attrius system based on cardiac PET technology enables healthcare providers to more accurately diagnose heart disease, improve patient outcomes, and practice cost effective medicine. It is also focused on increasing Sr-82 supply through the processing of proton irradiated target material from domestic and foreign suppliers; and recycling Sr-82 from spent generators. Positron Corporation was founded in 1983 and is based in Westmont, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Westmont"}, "PTQ.V": {"short_name": "PROTECH HOME MEDICAL CORP", "long_name": "Protech Home Medical Corp.", "summary": "Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VAN", "market": "ca_market", "country": "United States", "city": "Wilder"}, "PTQQF": {"short_name": "PROTECH HOME MEDICAL CORP", "long_name": "Protech Home Medical Corp.", "summary": "Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Wilder"}, "QTRX": {"short_name": "Quanterix Corporation", "long_name": "Quanterix Corporation", "summary": "Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Billerica"}, "RCEL": {"short_name": "Avita Therapeutics, Inc.", "long_name": "AVITA Medical, Inc.", "summary": "AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Valencia"}, "RFCS": {"short_name": "REFOCUS GROUP INC", "long_name": "Refocus Group, Inc.", "summary": "Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Dallas"}, "RMED": {"short_name": "Ra Medical Systems, Inc.", "long_name": "Ra Medical Systems, Inc.", "summary": "Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASE", "market": "us_market", "country": "United States", "city": "Carlsbad"}, "RMSL": {"short_name": "REMSLEEP HOLDINGS INC", "long_name": "REMSleep Holdings, Inc.", "summary": "REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It offers DeltaWave CPAP interface device to treat patients with sleep apnea. The company serves home care dealers, private sleep labs, Internet providers, product end users, physicians, medical group, and hospitals, as well as medical associations. REMSleep Holdings, Inc. was founded in 2007 and is headquartered in Orlando, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Orlando"}, "RSLS": {"short_name": "RESHAPE LIFESCIENCES INC", "long_name": "ReShape Lifesciences Inc.", "summary": "ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in morbidly obese patients without permanently cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Clemente"}, "RTSL": {"short_name": "RAPID THERAPEUTIC SCIENCE LBRTS", "long_name": "Rapid Therapeutic Science Laboratories, Inc.", "summary": "Rapid Therapeutic Science Laboratories, Inc. holds a sublicense agreement to access to certain technology regarding the RxoidTM metered dose inhaler (TMDI). The TMDI is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Dallas"}, "S0Z.F": {"short_name": "SIENTRA INC.  DL-,01", "long_name": "Sientra, Inc.", "summary": "Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Santa Barbara"}, "SCIE": {"short_name": "SPECTRASCIENCE INC", "long_name": "SpectraScience, Inc.", "summary": "SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Diego"}, "SDC": {"short_name": "SmileDirectClub, Inc.", "long_name": "SmileDirectClub, Inc.", "summary": "SmileDirectClub, Inc. operates a teledentistry platform that provides member's with a customized clear aligner therapy treatment in the United States and internationally. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment proprietary with a network of 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck. It offers aligners, impression kits, whitening gels, and retainers. The company was founded in 2014 and is headquartered in Nashville, Tennessee.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Nashville"}, "SDC.MX": {"short_name": "SMILEDIRECTCLUB INC", "long_name": "SmileDirectClub, Inc.", "summary": "SmileDirectClub, Inc. operates a teledentistry platform that provides member's with a customized clear aligner therapy treatment in the United States and internationally. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment proprietary with a network of 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck. It offers aligners, impression kits, whitening gels, and retainers. The company was founded in 2014 and is headquartered in Nashville, Tennessee.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Nashville"}, "SHOM": {"short_name": "SOUTHERN HOME MED INC", "long_name": "Southern Home Medical, Inc.", "summary": "Southern Home Medical, Inc. provides healthcare services to medical institutions in the United States. It supplies breathing equipment for patients with respiratory conditions; and oxygen concentrators, portable oxygen tanks, hospital beds, alternating pressure mattresses, patient lifts, tracheotomy supplies, commodes, walkers, and wheelchairs. The company also provides medical staffing needs to hospitals, rehab centers, nursing homes, mental health centers, and other medical facilities. It supports hospitals, rehab centers, nursing homes, and other medical facilities. Southern Home Medical, Inc. is based in Greer, South Carolina.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Greer"}, "SIBN": {"short_name": "SI-BONE, Inc.", "long_name": "SI-BONE, Inc.", "summary": "SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was founded in 2008 and is headquartered in Santa Clara, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Santa Clara"}, "SIEN": {"short_name": "Sientra, Inc.", "long_name": "Sientra, Inc.", "summary": "Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Santa Barbara"}, "SILK": {"short_name": "Silk Road Medical, Inc.", "long_name": "Silk Road Medical, Inc", "summary": "Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Sunnyvale"}, "SINT": {"short_name": "SiNtx Technologies, Inc.", "long_name": "Sintx Technologies, Inc.", "summary": "Sintx Technologies, Inc., a biomaterial company, researches, develops, manufactures, and commercializes a range of medical implant products manufactured with silicon nitride in the United States, Europe, and South America. It offers ceramic based biomaterial solutions in various medical and industrial applications. The company provides spine implant products under the Valeo brand to surgeons and hospitals for use in cervical and thoracolumbar spine surgery. Sintx Technologies, Inc. markets and sells its products directly; and through direct sales organizations, distributors, as well as original equipment manufacturer and private label partnerships. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was founded in 1996 and is headquartered in Salt Lake City, Utah.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Salt Lake City"}, "SMLR": {"short_name": "SEMLER SCIENTIFIC INC", "long_name": "Semler Scientific, Inc.", "summary": "Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. It offers its products through salespersons and distributors. The company was founded in 2007 and is headquartered in San Jose, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "San Jose"}, "SNDD": {"short_name": "REDHAWK HOLDINGS CORP", "long_name": "RedHawk Holdings Corp.", "summary": "RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells Sharps and Needle Destruction Devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanner. It also distributes WoundClot, a bleeding control medical device; Berrcom JXB178 infrared non-contact thermometers; and Zonis. In addition, RedHawk Holdings Corp. sells a line of face masks and face shields, including a level 1 single use disposable mask, a three layer level 3 cotton masks, and KN95 and N95 masks; an anti-fog and anti-static splash protection face shield; and a line of ultraviolet sanitation lights, including tabletop and handheld devices, as well as branded generic pharmaceuticals, such as Paracetamol, Glipizide, and Omeprazole. The company serves retail pharmacies, hospitals, physicians' offices, private and public healthcare clinics, corrections facilities, schools, veterinary clinics, emergency services, first responders, municipalities, and long term care facilities. In addition, it is involved in the commercial and residential property investment and leasing activities; sale of point of entry full-body security systems; and provision of specialized financial services. The company was formerly known as Independence Energy Corp. and changed its name to RedHawk Holdings Corp. in October 2015. RedHawk Holdings Corp. was incorporated in 2005 and is headquartered in Lafayette, Louisiana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Lafayette"}, "SNDZ": {"short_name": "SUNRIDGE INTERNATIONAL", "long_name": "Sunridge International, Inc.", "summary": "Sunridge International, Inc. manufactures and markets patented vacuum fixation devices and suction rings for the treatment of open angle and pigmentary glaucoma worldwide. It serves medical supply companies and health care providers. The company was founded in 1997 and is based in Fountain Hills, Arizona.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Fountain Hills"}, "SNWV": {"short_name": "SANUWAVE HEALTH INC", "long_name": "SANUWAVE Health, Inc.", "summary": "SANUWAVE Health, Inc., a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States, Europe, Canada, Asia, and the Asia Pacific. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device that has completed its Phase III clinical studies for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. It markets and sells its devices and accessories. SANUWAVE Health, Inc. was founded in 2005 and is headquartered in Suwanee, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Suwanee"}, "SOLY": {"short_name": "Soliton, Inc.", "long_name": "Soliton, Inc.", "summary": "Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Houston"}, "SPNE": {"short_name": "SeaSpine Holdings Corporation", "long_name": "SeaSpine Holdings Corporation", "summary": "SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. The company has development and licensing agreement with restor3d, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Carlsbad"}, "SRDX": {"short_name": "Surmodics, Inc.", "long_name": "Surmodics, Inc.", "summary": "Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Eden Prairie"}, "SRGA": {"short_name": "Surgalign Holdings, Inc.", "long_name": "Surgalign Holdings, Inc.", "summary": "Surgalign Holdings, Inc., a medical technology company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It offers coflex interlaminar stabilization device, an implant for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; SImmetry sacroiliac joint fusion system, which decreases in opioid use, pain, and disability; and Fortilink IBF system with TETRAfuse ?3D technology. The company's implants are used in the fields of orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force and various OEM relationships to healthcare providers, hospitals, and other healthcare facilities, as well as through a network of independent distributors. The company was founded in 1997 and is headquartered in Deerfield, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Deerfield"}, "SRTS": {"short_name": "Sensus Healthcare, Inc.", "long_name": "Sensus Healthcare, Inc.", "summary": "Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Boca Raton"}, "SSKN": {"short_name": "Strata Skin Sciences, Inc.", "long_name": "STRATA Skin Sciences, Inc.", "summary": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Horsham"}, "SSUR": {"short_name": "STATSURE DIAGNOSTIC SYSTEMS INC", "long_name": "StatSure Diagnostic Systems, Inc.", "summary": "StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices. The company was founded in 1986 and is based in Brooklyn, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Brooklyn"}, "STRR": {"short_name": "Star Equity Holdings, Inc.", "long_name": "Star Equity Holdings, Inc.", "summary": "Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Suwanee, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Suwanee"}, "STRRP": {"short_name": "Star Equity Holdings, Inc. - Se", "long_name": "Star Equity Holdings, Inc.", "summary": "Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Suwanee, Georgia.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Suwanee"}, "SU6.F": {"short_name": "SURMODICS  DL-,05", "long_name": "Surmodics, Inc.", "summary": "Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Eden Prairie"}, "SWAV": {"short_name": "ShockWave Medical, Inc.", "long_name": "ShockWave Medical, Inc.", "summary": "ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Santa Clara"}, "SWNM": {"short_name": "SOUTHWESTERN MEDICAL SOLUTIONS ", "long_name": "Southwestern Medical Solutions, Inc.", "summary": "Southwestern Medical Solutions, Inc. engages in the research and development of medical devices. The company offers LabGuard Accucheck, a device for on-site collection/analysis and testing to provide results for on-site diagnostic testing/screening market. The company was incorporated in 2003 and is based in Tampa, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Tampa"}, "SYK": {"short_name": "Stryker Corporation", "long_name": "Stryker Corporation", "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Kalamazoo"}, "SYK.DE": {"short_name": "STRYKER CORP.  DL-,10", "long_name": "Stryker Corporation", "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "GER", "market": "de_market", "country": "United States", "city": "Kalamazoo"}, "SYK.F": {"short_name": "STRYKER CORP.  DL-,10", "long_name": "Stryker Corporation", "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Kalamazoo"}, "SYK.MX": {"short_name": "STRYKER CORP", "long_name": "Stryker Corporation", "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.", "currency": "MXN", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MEX", "market": "mx_market", "country": "United States", "city": "Kalamazoo"}, "SYK.VI": {"short_name": "STRYKER CORP", "long_name": "Stryker Corporation", "summary": "Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "VIE", "market": "at_market", "country": "United States", "city": "Kalamazoo"}, "TCMD": {"short_name": "Tactile Systems Technology, Inc", "long_name": "Tactile Systems Technology, Inc.", "summary": "Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entr\u00c3\u00a9 System, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and ACTitouch system, a medical device for the treatment of venous leg ulcers chronic venous insufficiency patients. It also provides Airwear Gradient Compression Wrap that is used in the management of venous insufficiency, venous hypertension, venous ulcerations, and lymphedema under the trade name Aero-Wrap. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Minneapolis"}, "TD5A.F": {"short_name": "TANDEM DIABETES NEW -,001", "long_name": "Tandem Diabetes Care, Inc.", "summary": "Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "San Diego"}, "TELA": {"short_name": "TELA Bio, Inc.", "long_name": "TELA Bio, Inc.", "summary": "TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Malvern"}, "THMO": {"short_name": "ThermoGenesis Holdings, Inc.", "long_name": "ThermoGenesis Holdings, Inc.", "summary": "ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company operates through two segments, Device and Clinical Development. It manufactures and markets products for clinical bio-banking applications, including AXP Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company also offers PXP Point-of-Care System, an automated sterile system that allows for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification using the company's proprietary buoyance-activated cell sorting (BACS) technology. In addition, it provides AR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Rancho Cordova"}, "THRP.F": {"short_name": "THERMOGENESIS  DL-,001", "long_name": "ThermoGenesis Holdings, Inc.", "summary": "ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company operates through two segments, Device and Clinical Development. It manufactures and markets products for clinical bio-banking applications, including AXP Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company also offers PXP Point-of-Care System, an automated sterile system that allows for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification using the company's proprietary buoyance-activated cell sorting (BACS) technology. In addition, it provides AR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Rancho Cordova"}, "THRP.MU": {"short_name": "THERMOGENESIS  DL-,001", "long_name": "ThermoGenesis Holdings, Inc.", "summary": "ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company operates through two segments, Device and Clinical Development. It manufactures and markets products for clinical bio-banking applications, including AXP Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company also offers PXP Point-of-Care System, an automated sterile system that allows for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification using the company's proprietary buoyance-activated cell sorting (BACS) technology. In addition, it provides AR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "MUN", "market": "dr_market", "country": "United States", "city": "Rancho Cordova"}, "TJ9.F": {"short_name": "CUTERA INC.  DL-,001", "long_name": "Cutera, Inc.", "summary": "Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Brisbane"}, "TMDX": {"short_name": "TransMedics Group, Inc.", "long_name": "TransMedics Group, Inc.", "summary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion apparatus, optimization, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Andover"}, "TNDM": {"short_name": "Tandem Diabetes Care, Inc.", "long_name": "Tandem Diabetes Care, Inc.", "summary": "Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "San Diego"}, "TRXC": {"short_name": "TransEnterix, Inc.", "long_name": "TransEnterix, Inc.", "summary": "TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's products include Senhance Surgical System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and other select countries. The company was founded in 2006 and is based in Morrisville, North Carolina.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASE", "market": "us_market", "country": "United States", "city": "Morrisville"}, "TSNI": {"short_name": "TECHNISCAN INC", "long_name": "TechniScan, Inc.", "summary": "TechniScan, Inc., a development stage company, engages in the research, development, and commercialization of non-invasive medical imaging products for the detection and diagnosis of breast cancer. It intends to develop the Warm Bath Ultrasound system, an ultrasound-based imaging device that provides radiologists with information about the bulk properties of tissue in the breast, as well as images of the tissue structure. The company is based in Salt Lake City, Utah.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Salt Lake City"}, "UAHC": {"short_name": "UNITED AMERICAN HEALTHCARE INC", "long_name": "United American Healthcare Corporation", "summary": "United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Chicago"}, "ULGX": {"short_name": "UROLOGIX", "long_name": "Urologix, Inc.", "summary": "Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Minneapolis"}, "VA21.F": {"short_name": "VAPOTHERM INC. DL-,001", "long_name": "Vapotherm, Inc.", "summary": "Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Exeter"}, "VAPO": {"short_name": "Vapotherm, Inc.", "long_name": "Vapotherm, Inc.", "summary": "Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Exeter"}, "VG2B.F": {"short_name": "AVINGER INC.  DL-,001", "long_name": "Avinger, Inc.", "summary": "Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Redwood City"}, "VI4.F": {"short_name": "VAREX IMAGING CORP DL-,01", "long_name": "Varex Imaging Corporation", "summary": "Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Salt Lake City"}, "VIJ.F": {"short_name": "VIEMED HLTHCARE INC. O.N.", "long_name": "Viemed Healthcare, Inc.", "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Lafayette"}, "VIVE": {"short_name": "Viveve Medical, Inc.", "long_name": "Viveve Medical, Inc.", "summary": "Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, Canada, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Englewood"}, "VMD": {"short_name": "Viemed Healthcare, Inc.", "long_name": "Viemed Healthcare, Inc.", "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Lafayette"}, "VMD.TO": {"short_name": "VIEMED HEALTHCARE INC", "long_name": "Viemed Healthcare, Inc.", "summary": "Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.", "currency": "CAD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "TOR", "market": "ca_market", "country": "United States", "city": "Lafayette"}, "VRAY": {"short_name": "ViewRay, Inc.", "long_name": "ViewRay, Inc.", "summary": "ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. It has operations in the United States, France, Germany, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Oakwood"}, "VREX": {"short_name": "Varex Imaging Corporation", "long_name": "Varex Imaging Corporation", "summary": "Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys (a component of X-ray units that holds X-ray film cassettes). This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Salt Lake City"}, "VVOS": {"short_name": "Vivos Therapeutics, Inc.", "long_name": "Vivos Therapeutics, Inc.", "summary": "Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (SDB) comprising mild-to-moderate obstructive sleep apnea (OSA). The company's solutions cover proprietary alternatives for treating mild-to-moderate OSA; craniofacial and anatomical anomalies that are associated with mild-to-moderate OSA. Its treatment for OSA involves specially designed and customized oral appliances and treatment protocols. The company, through its Vivos Integrated Healthcare Network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate OSA. Vivos Therapeutics, Inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. It caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers, and patients in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2007 and is based in Highlands Ranch, Colorado.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NCM", "market": "us_market", "country": "United States", "city": "Highlands Ranch"}, "VYCO": {"short_name": "VYCOR MEDICAL  INC", "long_name": "Vycor Medical, Inc.", "summary": "Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage that caused by a stroke. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive, computer-based rehabilitation targeted at an un-addressed market of people who have lost their sight as a result of stroke or other brain injury. It offers therapies that restore and compensate for lost vision, including VRT that delivers a series of light stimuli along the border of the patient's visual field loss; VRT and NeET restoration therapies; and NeuroEyeCoach compensation or saccadic therapies for those suffering vision loss as a result of neurological trauma. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Boca Raton"}, "WCUI": {"short_name": "WELLNESS CTR USA INC", "long_name": "Wellness Center USA, Inc.", "summary": "Wellness Center USA, Inc. engages in the healthcare and medical businesses in the United States and internationally. It operates through Medical Devices, and Authentication and Encryption Products and Services segments. The company is primarily involved in the marketing and distribution of online sports and nutrition supplements. It also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices, including Psoria-Light that is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, the company offers Stealth Mark encryption and authentication solutions, which provide technologies within the security and supply chain management vertical sectors; and data intelligence services comprising proprietary, unprecedented, and actionable technology for industries, companies, and agencies. Wellness Center USA, Inc. was founded in 2010 and is based in Hoffman Estates, Illinois.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Hoffman Estates"}, "WGB.F": {"short_name": "INTEGER HLDGS  DL-,001", "long_name": "Integer Holdings Corporation", "summary": "Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac and neuromodulation products, such as batteries, capacitors, filtered feedthroughs, and implantable leads; implanted medical devices, pacemakers, implantable cardioverter defibrillators, implantable cardiac pacing and defibrillation leads, and heart failure therapies, such as ventricular assist devices and cardiac resynchronization devices. In addition, the company offers rechargeable batteries and chargers, and non-rechargeable batteries; arthroscopic devices and components, including shaver blades and burrs, ablation probes, and suture anchors; and laparoscopic and general surgery products, such as harmonic scalpels, radio frequency probes, and ophthalmic surgery devices. Further, it provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Plano"}, "WLSI": {"short_name": "WELLSTAR INTERNATIONAL INC", "long_name": "Wellstar International, Inc.", "summary": "Wellstar International, Inc. does not have significant operations. Previously, the company, through its subsidiary, Trillennium Medical Imaging, Inc., engaged in developing and licensing advanced thermal imaging technology in the consumer health care markets. Its technology enabled a diagnostic screening procedure for the early breast cancer detection; the differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; and the detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Wellstar International, Inc. was founded in 1997 and is based in Holland, Ohio.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Holland"}, "WTKN": {"short_name": "WELLTEK INCORP", "long_name": "WellTek Incorporated", "summary": "WellTek Incorporated operates as a health, fitness, and wellness company that provides solutions to address obesity, and chronic neck and back pain in the United States. It engages in the manufacture, market, and distribution of medical, rehabilitation, and exercise equipment. The company also involves in building a network of medical back and neck rehabilitation centers offering a proprietary program to managed care companies, self-insured employer groups, and federal government agencies. In addition, it operates a social networking site, which allows in reaching, engaging, and influencing health and wellness conscious consumers with new and existing brand assets, technologies, products, and services. WellTek Incorporated was founded in 2003 and is headquartered in Orlando, Florida.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Orlando"}, "XAIR": {"short_name": "Beyond Air, Inc.", "long_name": "Beyond Air, Inc.", "summary": "Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of lung infections, persistent pulmonary hypertension of the newborn, severe acute respiratory syndrome coronavirus 2, bronchiolitis, and nontuberculous mycobacteria.The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NMS", "market": "us_market", "country": "United States", "city": "Garden City"}, "XCRP": {"short_name": "XCORPOREAL INC", "long_name": "Xcorporeal, Inc.", "summary": "Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "PNK", "market": "us_market", "country": "United States", "city": "Lake Forest"}, "XEJ.F": {"short_name": "ACCURAY INC.  DL -,001", "long_name": "Accuray Incorporated", "summary": "Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Sunnyvale"}, "XENT": {"short_name": "Intersect ENT, Inc.", "long_name": "Intersect ENT, Inc.", "summary": "Intersect ENT, Inc., a drug delivery company, researches and develops products for the treatment of patients with ear, nose, and throat conditions in the United States. The company offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NGM", "market": "us_market", "country": "United States", "city": "Menlo Park"}, "XMS.F": {"short_name": "XTANT MEDICAL HLDGS", "long_name": "Xtant Medical Holdings, Inc.", "summary": "Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.", "currency": "EUR", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "FRA", "market": "dr_market", "country": "United States", "city": "Belgrade"}, "XTNT": {"short_name": "Xtant Medical Holdings, Inc.", "long_name": "Xtant Medical Holdings, Inc.", "summary": "Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation system; Spider cervical plating system; Axle Interspinous Fusion System; Silex Sacroiliac joint fusion system; Xpress minimally invasive pedicle screw system; and Fortex Pedicle screw system. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "ASE", "market": "us_market", "country": "United States", "city": "Belgrade"}, "ZBH": {"short_name": "Zimmer Biomet Holdings, Inc.", "long_name": "Zimmer Biomet Holdings, Inc.", "summary": "Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.", "currency": "USD", "sector": "Healthcare", "industry": "Medical Devices", "exchange": "NYQ", "market": "us_market", "country": "United States", "city": "Warsaw"}}